Monument Legal Represents Air Force Major Jason Watson, Arrested on Capitol Steps After Calling for Impeachment

WASHINGTON, July 8, 2026 /PRNewswire/ — Monument Legal partner Christopher J. Mutimer will represent Air Force Major Jason P. Watson, the active-duty officer arrested on the Capitol steps after publicly calling for the impeachment of the President and Vice President. Mutimer specializes… Source: prnewswire Country: United States

Home Sleep Apnea Testing Market to Reach USD 996.6 Million by 2036, Driven by Expanding Telehealth Adoption and Rising Demand for Portable Sleep Diagnostics

NEWARK, Del., July 8, 2026 /PRNewswire/ — According to Future Market Insights (FMI), the global home sleep apnea testing market is projected to grow from USD 734.4 million in 2026 to USD 996.6 million by 2036, registering a 3.1% CAGR during the forecast period. Rising demand for… Source: prnewswire Country: United States

Trilogy Metals Reports Second Quarter Fiscal 2026 Results and Provides Update on Federal Permitting Progress and Project Advancement

VANCOUVER, BC, July 8, 2026 /PRNewswire/ – Trilogy Metals Inc. (TSX: TMQ) (NYSE American: TMQ) (“Trilogy Metals” or the “Company”) announces its financial results for the second quarter ended May 31, 2026, and provides an update on the federal permitting process for the Arctic Project,… Source: prnewswire Country: United States

Hyperscale Data Reaffirms 2026 Revenue Guidance of $180 Million to $200 Million and Plans to Hold a Stockholder Conference Call in the Third Quarter to Discuss Ault Capital Group Divestiture and Long-

Recently Announced Master Services Agreement Valued at Approximately $1.2 Billion to as Much as $3.0 Billion Positions Company for Future Revenue Growth and Improving Cash Flow LAS VEGAS, July 8, 2026 /PRNewswire/ — Hyperscale Data, Inc. (NYSE American: GPUS), an artificial intelligence… Source: prnewswire Country: United States

OneMain Holdings Announces Date of Second Quarter 2026 Earnings Release and Conference Call

NEW YORK, July 8, 2026 /PRNewswire/ — OneMain Holdings, Inc. (NYSE: OMF), the leader in offering nonprime consumers responsible access to credit, plans to report its second quarter 2026 results before the market opens on Wednesday, July 29, 2026. The earnings release will be available on… Source: prnewswire Country: United States

Nationally Recognized Computer Engineering Expert Witness Joshua Goshorn Joins Quandary Peak Research

One of the country’s most experienced software expert witnesses joins Quandary Peak to support clients in complex software litigation. LOS ANGELES, July 8, 2026 /PRNewswire/ — Quandary Peak Research announced today that Joshua Goshorn has joined the firm as Senior Director, strengthening… Source: prnewswire Country: United States

Choreo Acquires Resource Financial Group Assets

Business Planning-Focused RIA with $700 Million in Assets Expands Firm’s Chicago-Area Footprint CHICAGO, July 8, 2026 /PRNewswire/ — Choreo, LLC (“Choreo”) today announced it has acquired substantially all the assets of Resource Financial Group (“RFG”), a Wilmette, Illinois-based… Source: prnewswire Country: United States

Yatsen Group Announces Partnership with Sephora China, Cementing Position as a Science-Led Beauty Innovation Leader

GUANGZHOU, China, July 8, 2026 /PRNewswire/ — Yatsen Group (NYSE: YSG), a world-class beauty innovation pioneer, recently announced a landmark collaboration to bring its flagship brand, Perfect Diary, to Sephora in China. This partnership integrates Yatsen’s rigorous scientific… Source: prnewswire Country: United States

Azentio launches UAE E-Invoicing solution with pre-approved ASP status and AI-powered ERP capabilities

DUBAI, UAE, July 8, 2026 /PRNewswire/ — Azentio Software, a leading provider of specialized BFSI and ERP software solutions in emerging markets, has announced the launch of its UAE E-Invoicing solution, following its designation as a pre-approved Accredited Service Provider (ASP) by the… Source: prnewswire Country: United States

Grünenthal receives FDA Orphan Drug and Rare Pediatric Disease Designations for Tegacorat for the Treatment of Duchenne Muscular Dystrophy

AACHEN, Germany, July 8, 2026 /PRNewswire/ — Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD)…. Source: prnewswire Country: United States